This inventor holds 1 USPTO granted patent. Top assignee: Shilpa Mecicare Limited. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Venkata Reddy Gayam: Innovator in Pharmaceutical Processes
Introduction
Venkata Reddy Gayam is a notable inventor based in Raichur, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes for drug formulations. His work is characterized by a focus on innovative solutions that can enhance treatment options for patients.
Latest Patents
Venkata Reddy Gayam holds a patent for a process related to crystalline pemetrexed dipotassium salt. The patent, titled "Process for crystalline pemetrexed dipotassium salt," outlines a method for preparing crystalline Pemetrexed dipotassium (I) Form-SP9. This process is distinguished by its X-ray powder diffraction pattern, which includes at least five characteristic 2θ peaks selected from a specific XRPD peak set. The invention also details a process for preparing pharmaceutical compositions that may be beneficial for anti-cancer treatment. He has 1 patent to his name.
Career Highlights
Venkata Reddy Gayam is associated with Shilpa Medicare Limited, where he applies his expertise in pharmaceutical processes. His role at the company allows him to contribute to the development of innovative drug formulations that can improve patient outcomes.
Collaborations
Throughout his career, Venkata has collaborated with talented individuals such as Bhagat Raj Pipal and Akshay Kant Chaturvedi. These collaborations have fostered a creative environment that encourages the exchange of ideas and advancements in pharmaceutical research.
Conclusion
Venkata Reddy Gayam is a distinguished inventor whose work in pharmaceutical processes has the potential to impact cancer treatment significantly. His innovative approach and dedication to research exemplify the spirit of invention in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile